MicroRNA-200b targets CREB1 and suppresses cell growth in human malignant glioma (Q39173282)

9 September 2017

MicroRNA-200b targets CREB1 and suppresses cell growth in human malignant glioma (English)

1 reference

9 September 2017

1 reference

1 reference

Biao Peng

1

1 reference

9 September 2017

Su Hu

2

1 reference

9 September 2017

Qinming Jun

3

1 reference

9 September 2017

Dongdong Luo

4

1 reference

9 September 2017

Xun Zhang

5

1 reference

9 September 2017

Hailin Zhao

6

1 reference

9 September 2017

Dan Li

7

1 reference

9 September 2017

30 March 2013

1 reference

Molecular and Cellular Biochemistry

9 September 2017

1 reference

9 September 2017

379

1 reference

9 September 2017

1-2

1 reference

9 September 2017

51-58

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-013-1626-6

9 September 2017

0 references

cites work

Recent advances in therapy for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

MicroRNA control of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

MicroRNAs, cancer and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

Review of miR-200b and cancer chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

Transcriptional regulation by the phosphorylation-dependent factor CREB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

Overexpression and RNA interference of Ap-cyclic AMP-response element binding protein-2, a repressor of long-term facilitation, in Aplysia kurodai sensory-to-motor synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1626-6

The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23543137

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

cAMP response element binding protein (CREB) overexpression CREB has been described as critical for leukemia progression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23543137

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

MicroRNAs as oncogenes and tumor suppressors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23543137

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11010-013-1626-6

1 reference

9 September 2017

1 reference